Paper42657381
Diagnostic value and prognostic effect of has-miR-151a-3p in tuberculosis.
Li J and 1 other. J Res Med Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Diagnostic value and prognostic effect of has-miR-151a-3p in tuberculosis. Papers, record 42657381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42657381
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36793717 | Screening for diagnostic targets in tuberculosis and study on its pathogenic mechanism based on mRNA sequencing technology and miRNA-mRNA-pathway regulatory network. | Front Immunol | 2023 | https://conductscience.org/library/papers/36793717 | PubMed |
| 2 | 40993612 | Analysis of miR-151a-3p as a biomarker of osteoarthritis and its clinical value. | J Orthop Surg Res | 2025 | https://conductscience.org/library/papers/40993612 | PubMed |
| 3 | 33716195 | Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. | Int J Infect Dis | 2021 | https://conductscience.org/library/papers/33716195 | PubMed |
| 4 | 31199066 | MiR-140 modulates the inflammatory responses of Mycobacterium tuberculosis-infected macrophages by targeting TRAF6. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/31199066 | PubMed |
| 5 | 21475309 | Immunological biomarkers of tuberculosis. | Nat Rev Immunol | 2011 | https://conductscience.org/library/papers/21475309 | PubMed |
| 6 | 23686117 | Tuberculosis: lights and shadows in the current diagnostic landscape. | New Microbiol | 2013 | https://conductscience.org/library/papers/23686117 | PubMed |
| 7 | 30904262 | Tuberculosis. | Lancet | 2019 | https://conductscience.org/library/papers/30904262 | PubMed |
| 8 | 24358114 | MicroRNA-146a represses mycobacteria-induced inflammatory response and facilitates bacterial replication via targeting IRAK-1 and TRAF-6. | PLoS One | 2013 | https://conductscience.org/library/papers/24358114 | PubMed |
| 9 | 11099028 | Surfing the p53 network. | Nature | 2000 | https://conductscience.org/library/papers/11099028 | PubMed |
| 10 | 35305574 | High miRNA-378 expression has high diagnostic values for pulmonary tuberculosis and predicts adverse outcomes. | BMC Mol Cell Biol | 2022 | https://conductscience.org/library/papers/35305574 | PubMed |
| 11 | 17197185 | Repression of protein synthesis by miRNAs: how many mechanisms? | Trends Cell Biol | 2007 | https://conductscience.org/library/papers/17197185 | PubMed |
| 12 | 9039259 | p53, the cellular gatekeeper for growth and division. | Cell | 1997 | https://conductscience.org/library/papers/9039259 | PubMed |
| 13 | 26296289 | miR-223 is upregulated in monocytes from patients with tuberculosis and regulates function of monocyte-derived macrophages. | Mol Immunol | 2015 | https://conductscience.org/library/papers/26296289 | PubMed |
| 14 | 218111 | T antigen is bound to a host protein in SV40-transformed cells. | Nature | 1979 | https://conductscience.org/library/papers/218111 | PubMed |
| 15 | 26505221 | MicroRNA-223 Is Upregulated in Active Tuberculosis Patients and Inhibits Apoptosis of Macrophages by Targeting FOXO3. | Genet Test Mol Biomarkers | 2015 | https://conductscience.org/library/papers/26505221 | PubMed |
| 16 | 22496353 | Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. | J Infect Dis | 2012 | https://conductscience.org/library/papers/22496353 | PubMed |
| 17 | 23531389 | Tuberculosis biomarkers discovery: developments, needs, and challenges. | Lancet Infect Dis | 2013 | https://conductscience.org/library/papers/23531389 | PubMed |
| 18 | 39832042 | Nonylphenol promotes epithelial-mesenchymal transition in colorectal cancer cells by upregulating miR-151a-3p. | Discov Oncol | 2025 | https://conductscience.org/library/papers/39832042 | PubMed |
| 19 | 20466923 | The population dynamics and control of tuberculosis. | Science | 2010 | https://conductscience.org/library/papers/20466923 | PubMed |
| 20 | 28912881 | Immune regulation of miR-30 on the Mycobacterium tuberculosis-induced TLR/MyD88 signaling pathway in THP-1 cells. | Exp Ther Med | 2017 | https://conductscience.org/library/papers/28912881 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42657381
GET https://conductscience.org/api/papers/v1/42657381/references?page=2